Synchrony Financial (SYF) recently experienced a significant change in its shareholding pattern as a variety of companies bought or sold shares. Companies like Stevens Capital Management LP, NEOS Investment Management LLC, First National Bank of Omaha, and Assetmark Inc. acquired significant numbers of shares, while others including Baird, Vanguard Group Inc., Aberdeen Group, and Todd Asset Management LLC significantly reduced their holdings. There's also been an 11% slide in share prices, possibly influenced by recent financial performance and future expectations. Despite this, Synchrony Financial realized strong earnings with record purchase volumes and capital returns. Its CareCredit expansion strategy into dental workflows has been met with mixed reactions. Evaluations indicate potential growth, but regulatory uncertainties and recent credit portfolio disclosures have raised some concerns. Analyst's consensus rates Synchrony Financial as a Moderate Buy.
Synchrony Financial SYF News Analytics from Wed, 23 Jul 2025 07:00:00 GMT to Sat, 21 Feb 2026 13:58:57 GMT -
Rating -4
- Innovation 6
- Information 2
- Rumor -8
